This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Scandion Oncology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

What is the ownership structure of SCOL BTA?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	2,367,047	5.81%
General Public	38,339,925	94.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 26.7%.

Top 14 shareholders own 5.81% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
3.42%	Jan Stenvang	1,391,519	SEK 8.2m	0%	no data
1.05%	Jorgen Vilhelm Bardenfleth	425,629	SEK 2.5m	0%	no data
0.34%	Peter Vestlev	140,297	SEK 827.7k	0%	no data
0.28%	Carl Arne Borrebaeck	112,165	SEK 661.8k	0%	no data
0.16%	Carit Andersen	65,360	SEK 385.6k	0%	no data
0.15%	Peter Hongaard Andersen	62,065	SEK 366.2k	0%	no data
0.1%	Bo Hansen	42,442	SEK 250.4k	0%	no data
0.075%	Nicklas Roest	30,688	SEK 181.1k	0%	no data
0.069%	Thomas Feldthus	28,182	SEK 166.3k	0%	no data
0.059%	Maj Hedtjarn	24,000	SEK 141.6k	0%	no data
0.049%	Annie Rasmussen	20,000	SEK 118.0k	0%	no data
0.025%	Christian Thomsen	10,000	SEK 59.0k	0%	no data
0.025%	Johnny Stilou	10,000	SEK 59.0k	0%	no data
0.012%	Martin Moller	4,700	SEK 27.7k	0%	no data